Medical Research
(H50)
IRS Verified
DX Registered
990 on File
MPN RESEARCH FOUNDATION
Financial strength (30%)
92/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of MPN Research Foundation is to stimulate original research in pursuit of new treatments — and eventually a cure — for the blood cancers essential thrombocythemia, polycythemia vera, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN).
Financial Overview — FY 2024
$3.6M
Total Revenue
$3.8M
Total Expenses
$6.8M
Net Assets
12
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
82.4%
Fundraising Efficiency
N/A
Operating Reserve
21.59x
Liability-to-Asset
15.6%
Revenue Diversification
93.7%
Executive Compensation
$703K
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
82.4% | 83.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.7% | 10.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.9% | 2.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.6 mo | 12.8 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
15.6% | 10.1% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.7% | 90.7% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
46.2% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
15.5% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-4.9% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $3.6M | $3.8M | $6.8M | 82.4% | 12 |
| 2023 | $2.5M | $3.3M | $6.4M | 78.1% | 10 |
| 2022 | $3.9M | $3.7M | $6.7M | 86.1% | 8 |
| 2021 | $2.6M | $2.0M | N/A | — | 10 |
| 2020 | $6.5M | $2.7M | N/A | — | 9 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.